Guidelines for the Long-Term Use of Nsaids in Cats

Total Page:16

File Type:pdf, Size:1020Kb

Guidelines for the Long-Term Use of Nsaids in Cats Journal of Feline Medicine and Surgery (2010) 12, 521–538 doi:10.1016/j.jfms.2010.05.004 SPECIAL ARTICLE ISFM AND AAFP CONSENSUS GUIDELINES Long-term use of NSAIDs in cats NSAIDs and cats Non-steroidal anti-inflammatory drugs (NSAIDs) are an important class Andrew H Sparkes of drug in feline medicine, having analgesic, anti-inflammatory and antipyretic activity. While BVetMed PhD DipECVIM MRCVS Panel Chair, International Society most published data on their use in this species relate to short-term (often perioperative) of Feline Medicine therapy, there is increasing evidence of the value of these drugs in treating chronic pain in Reidun Heiene cats (for example, that associated with degenerative joint disease), and some NSAIDs have DVM PhD MRCVS now become licensed for long-term use in cats in some geographies. Most of our knowledge Associate Professor, Department of Companion Animals of therapeutic mechanisms or adverse drug reactions associated with NSAIDs is extrapolated Clinical Sciences, from work in other species, and there is a paucity of published data relating to cats. Norwegian School of Veterinary Sciences, Oslo, Norway Guidelines These guidelines have been drawn together by an expert panel, which have reviewed the current literature on long-term NSAID use in cats and other species, and developed guidance on their B Duncan X Lascelles BSc BVSc PhD MRCVS CertVA use based on this information. The aim is to provide practical information for veterinarians to encourage DSAS(ST) DipECVS DipACVS appropriate NSAID therapy whenever cats will benefit from the use of these drugs. Associate Professor of Surgery, Director, Comparative Pain Research Laboratory, Director, Integrated Pain Introduction Management Service, Chronic pain can be regarded as pain that North Carolina State University has persisted for more than 2–3 weeks, often College of Veterinary Medicine, Pain in cats has many negative effects, both persists months or years, and may continue Raleigh, NC 27606, USA physiological and emotional.1,2 It is now beyond the anticipated healing time. Richard Malik DVSc DipVetAn MVetClinStud accepted that there is no such thing as ‘good Importantly, chronic pain can become dissociat- PhD FACVSc FASM pain’ following surgery and during treatment ed from the inciting cause and be maladaptive, Centre for Veterinary Education, for trauma or disease – eg, pain that inhibits such that the degree of pain does not necessar- The University of Sydney, Camperdown, NSW 2006, Australia potentially deleterious movement after sur- ily correlate with the pathology observed or Llibertat Real Sampietro gery. Pain delays recovery, impacts negatively perceived by the individual, and is not associat- DVM 12 on a patient’s wellbeing, and disturbs the bond ed with healing. Multimodal analgesia is Clinica Veterinaria Bendinat, with its owner and also the veterinary team.1,3 commonly advocated, but it is becoming Mallorca, Spain Studies have looked at the use of non- evident that NSAIDs will play a key role in Sheilah Robertson BVMS (Hons) PhD CVA DACVA steroidal anti-inflammatory drugs (NSAIDs) for managing chronic feline pain, especially mus- DECVAA MRCVS 4–7 acute, especially perioperative, pain in cats. culoskeletal pain, just as they do in humans and Section of Anesthesia and Surveys have shown clinicians were more likely dogs.10,13–16 Until quite recently, while many Pain Management, 8,9 College of Veterinary Medicine, to treat pain in dogs than cats, as a result of dif- NSAIDs have been available to treat dogs with University of Florida, Gainesville, ficulties in recognising pain, lack of knowledge degenerative joint disease (DJD),17 only a Florida 32610, USA concerning the use of analgesics, and fear of restricted range has been licensed for short- Margie Scherk drug side effects in cats. Less has been published term (up to a few days) use in cats. At the time DVM DABVP (Feline Practice) CatsINK, Vancouver, BC, Canada on the management of chronic pain in cats, but of writing, at least one NSAID – meloxicam – Polly Taylor it is recognised that signs may be subtle and has been licensed for long-term use in cats in MA VetMB PhD DVA MRCVS include withdrawing from attention, decreased many regions of the world, transforming our Taylor Monroe, Ely, UK mobility, reduced interactions with humans and ability to manage pain in this species, and a other animals, poor appetite and aggression.10–12 second – robenacoxib – has been licensed for up STRATEGIC PARTNERS IN FELINE HEALTH AND WELFARE TOGETHER IMPROVING CATS’ LIVES WORLDWIDE Collaborating to build a future of unparallelled cat care by: ✜ Raising the profile of the cat in the veterinary clinic ✜ Creating continuing education opportunities for veterinary care professionals ✜ Developing practice guidelines to facilitate high standards of feline health care ✜ Providing tools and resources to improve veterinary skills and knowledge © 2010 Published by Elsevier Ltd on behalf of ISFM and AAFP. JFMS CLINICAL PRACTICE 521 SPECIAL ARTICLE / ISFM/AAFP guidelines on NSAIDs Pain delays recovery, impacts negatively on a patient’s wellbeing, and disturbs the bond with its owner and also the veterinary team. aa to 6 days of therapy in cats (see Table 1, page 529). There is little doubt that others will become licensed for long-term use in the future, due to the recognition of the need and value for such NSAID therapy in this species.10,11,13–15,18 FIG 1 (a,b) Clinicians are aware of their duty to promote Degenerative joint disease of animal welfare and relieve suffering, but are the elbow in a also often reminded of Hippocrates’ advice to feline patient ‘first do no harm’. This is often rightly used to b question whether an intervention will actually do more harm than good, and to withhold that intervention when doubts exist. However, we need also to recognise that withholding treat- ments such as analgesics can sometimes cause the greater harm, because we are no longer addressing the pain and suffering the animal b is enduring. In drawing up these guidelines, FIG 2 Anteroposterior the international panel of experts’ purpose has (a) and lateral (b) radiographs of the been to review the current literature on long- hock of a Scottish term NSAID use in cats, and to provide practi- fold cat with severe osteochondrodysplasia, cal guidance on their use. The overarching aim showing destruction is to encourage more widespread and appro- of joint spaces priate NSAID therapy, when cats will benefit and extensive plantar exostosis. from the use of these drugs. However, most of Courtesy of Kim Kendall our knowledge of therapeutic mechanisms or adverse drug reactions is extrapolated from work in other species, as there is a paucity of published data relating to cats. Common causes of chronic pain and inflammation in cats One of the difficulties in managing pain in cats is FIG 3 Watson, a DJD sufferer, enjoying its initial recognition. It is important, therefore, to the benefits of daily NSAID treatment be aware of common causes of pain and to have a high index of suspicion for signs and behav- iours potentially related to pain. If something is clinical disease is present many owners may painful to us, it is likely to be painful to a cat. simply assume a cat is ‘getting old’, and even educated and attentive owners may not neces- Degenerative joint disease sarily appreciate suffering associated with DJD The most common cause of chronic feline pain without veterinary observation and insight. is thought to be DJD, and this has been the sub- In the absence of medical intervention, many ject of a number of important studies in the past cats with DJD suffer pain and discomfort for 10 years.11,15,16,18–24 From these studies, it is clear years, greatly affecting their quality of life and that DJD is very common, with radio graphic the human/feline bond. It is vital that examina- changes affecting up to 60–90% of cats (Figs 1 tions of the older feline patient should specifi- and 2),18,24 that it affects both the spine and the cally address whether DJD is present, through appendicular joints, and that it occurs especial- history and physical examination and, where ly commonly in older patients.18,24 The hips, necessary, radiology and therapeutic trials. stifle, shoulder, elbow, tarsus and spine are Control of bodyweight, exercise and environ- the most common sites affected, although other mental modifications may help cats with DJD, joints can also be involved. Studies based on as may other medical therapies. However, the radiographic findings have limitations, though, dramatic responses reported to NSAIDs13,21,23 as the changes observed do not necessarily cor- indicate that there is a huge scope for safe, respond to clinical disease, or the severity of effective long-term NSAID therapy in the large clinical disease and pain. Nevertheless, where cohort of aged cats with DJD (Fig 3). 522 JFMS CLINICAL PRACTICE SPECIAL ARTICLE / ISFM/AAFP guidelines on NSAIDs Other diseases There are many other feline diseases where If something is painful to us, control of protracted inflammation and pain is it is likely to be painful to a cat. important. These include various cancers (Fig 4a), particularly where definitive treatment is not possible, or in some cases for the anti - neoplastic effect NSAIDs may offer.25–28 Other control of fever with NSAIDs may also be common conditions associated with chronic valuable in some situations. A short therapeu- pain where NSAIDs may form part of therapy tic trial of an NSAID without a definitive diag- include trauma, lymphoplasmacytic gingivo - nosis may sometimes be appropriate, using stomatitis (Fig 5),29 idiopathic cystitis,30,31 skin the response to treatment as a guide to diag- disease and uveitis (Fig 6). In the last, both nosis and further therapy.
Recommended publications
  • Mechanisms of Damage to the Gastrointestinal Tract from Non-Steroidal Anti-Inflammatory Drugs
    Mechanisms of damage to the gastrointestinal tract from non-steroidal anti-inflammatory drugs BJARNASON, Ingvar, SCARPIGNATO, Carmelo, HOLMGREN, Erik, OLSZEWSKI, Michael, RAINSFORD, Kim and LANAS, Angel Available from Sheffield Hallam University Research Archive (SHURA) at: http://shura.shu.ac.uk/17716/ This document is the author deposited version. You are advised to consult the publisher's version if you wish to cite from it. Published version BJARNASON, Ingvar, SCARPIGNATO, Carmelo, HOLMGREN, Erik, OLSZEWSKI, Michael, RAINSFORD, Kim and LANAS, Angel (2017). Mechanisms of damage to the gastrointestinal tract from non-steroidal anti-inflammatory drugs. Gastroenterology, 154 (3), 500-514. Copyright and re-use policy See http://shura.shu.ac.uk/information.html Sheffield Hallam University Research Archive http://shura.shu.ac.uk Accepted Manuscript Mechanisms of Damage to the Gastrointestinal Tract From Non-steroidal Anti- inflammatory Drugs Ingvar Bjarnason, Carmelo Scarpignato, Erik Holmgren, Michael Olszewski, Kim D. Rainsford, Angel Lanas PII: S0016-5085(17)36666-0 DOI: 10.1053/j.gastro.2017.10.049 Reference: YGAST 61566 To appear in: Gastroenterology Accepted Date: 31 October 2017 Please cite this article as: Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A, Mechanisms of Damage to the Gastrointestinal Tract From Non-steroidal Anti-inflammatory Drugs, Gastroenterology (2018), doi: 10.1053/j.gastro.2017.10.049. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form.
    [Show full text]
  • A PREDICTIVE MULTISCALE MODEL of DRUG TRANSPORT By
    FROM CELL TO ORGANISM: A PREDICTIVE MULTISCALE MODEL OF DRUG TRANSPORT by Xinyuan Zhang A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Pharmaceutical Sciences) in The University of Michigan 2010 Doctoral Committee: Associate Professor Gustavo Rosania, Chair Professor Gordon L. Amidon Professor Steven P. Schwendeman Professor Shuichi Takayama © Xinyuan Zhang 2010 To my parents and my husband With all my love and thanks ii ACKNOWLEDGEMENTS I would like to thank my advisor, Dr. Gus R. Rosania, for all of his insightful and valuable guidance during my Ph.D. study. I learned not only scientific knowledge from him, but also the way and attitude of doing science, being honest, creative, and open. His office door is always open and whenever I had questions, I always felt free to go and ask. I am grateful for his continuous support to many decisions I made, such as pursuing Master’s degree in Statistics, doing an internship in my last year of study, and attending many conferences to present my work. I would also like to thank my dissertation committee members, Dr. Gordon L. Amidon, Dr. Steven P. Schwendeman, and Dr. Shuichi Takayama, for their valuable time, suggestions, and input. All the unexpected questions, challenges, discussions, and suggestions made me think further and more deeply about my project. I would like to thank Dr. Stefan Trapp from the Technical University of Denmark and Dr. Richard W. Horobin from the University of Glasgow, for their help with the original model. I thank Dr. Kerby Shedden from the Department of Statistics of the University of Michigan, for all the discussions about my project.
    [Show full text]
  • Measurement of Quantum State: Adequatio Intellectus Nostri Cum Re -A Zeitgeist Model
    International Journal of Scientific and Research Publications, Volume 2, Issue 11, November 2012 1 ISSN 2250-3153 MEASUREMENT OF QUANTUM STATE: ADEQUATIO INTELLECTUS NOSTRI CUM RE -A ZEITGEIST MODEL Dr K N Prasanna Kumar, Prof B S Kiranagi, Prof C S Bagewadi ABSTRACT: Serge Haroche and David Wineland were awarded Nobel Prize in Physics for being able to resolve the conflict of Quantum measurement. We give a concomitant model for the same. Study of concatenated equation is done in the next paper. INTRODUCTION: Believe nothing on the faith of traditions, even though they have been held in honor for many generations and in diverse places. Do not believe a thing because many people speak of it. Do not believe on the faith of the sages of the past. Do not believe what you yourself have imagined, persuading yourself that a God inspires you. Believe nothing on the sole authority of your masters and priests. After examination, believe what you yourself have tested and found to be reasonable, and conform your conduct thereto. As the Buddha was dying, Ananda asked who would be their teacher after death. He replied to his disciple - "Be lamps unto yourselves. Be refuges unto yourselves. Take yourself no external refuge. Hold fast to the truth as a lamp. Hold fast to the truth as a refuge. Look not for a refuge in anyone besides yourselves. And those, Ananda, who either now or after I am dead, Shall be a lamp unto themselves, Shall betake themselves as no external refuge, But holding fast to the truth as their lamp, Holding fast to the truth as their refuge, Shall not look for refuge to anyone else besides themselves, www.ijsrp.org International Journal of Scientific and Research Publications, Volume 2, Issue 11, November 2012 2 ISSN 2250-3153 It is they who shall reach to the very topmost height; But they must be anxious to learn." Quoted in Joseph Goldstein, The Experience of Insight Buddha Unbounded by time and space.
    [Show full text]
  • BRS Pharmacology
    Pharmacology i Pharmacology Gary C. Rosenfeld, PhD Professor Department of Integrated Biology and Pharmacology and Graduate School of Biomedical Sciences Assistant Dean for Education Programs University of Texas Medical School at Houston Houston, Texas David S. Loose, PhD Associate Professor Department of Integrated Biology and Pharmacology and Graduate School of Biomedical Sciences University of Texas Medical School at Houston Houston, Texas iii Acquisitions Editor: Sirkka Howes Product Manager: Catherine Noonan Marketing Manager: Joy Fisher-Williams Vendor Manager: Bridgett Dougherty Manufacturing Coordinator: Margie Orzech Design Coordinator: Holly McLaughlin Compositor: Integra Software Services Pvt. Ltd. Sixth Edition Copyright © 2014, 2010, 2007, 1998 Lippincott Williams & Wilkins, a Wolters Kluwer business. 351 West Camden Street Two Commerce Square Baltimore, MD 21201 2001 Market Street Philadelphia, PA 19103 Printed in China All rights reserved. This book is protected by copyright. No part of this book may be reproduced or transmitted in any form or by any means, including as photocopies or scanned-in or other electronic copies, or utilized by any information storage and retrieval system without written permission from the copyright owner, except for brief quotations embodied in critical articles and reviews. Materials appearing in this book prepared by individuals as part of their official duties as U.S. government employees are not covered by the above-mentioned copyright. To request permission, please contact Lippincott Williams & Wilkins at 2001 Market Street, Philadelphia, PA 19103, via email at [email protected], or via website at lww.com (products and services). 9 8 7 6 5 4 3 2 1 Library of Congress Cataloging-in-Publication Data Rosenfeld, Gary C.
    [Show full text]
  • Locating Chelerythrine, an Alkaloid, Within a Cytosolic Environment by Maldi-Tof Mass Spectrometry
    Wright State University CORE Scholar Browse all Theses and Dissertations Theses and Dissertations 2013 Locating Chelerythrine, an Alkaloid, within a Cytosolic Environment by Maldi-Tof Mass Spectrometry Bradley Allen Williams Wright State University Follow this and additional works at: https://corescholar.libraries.wright.edu/etd_all Part of the Pharmacology, Toxicology and Environmental Health Commons Repository Citation Williams, Bradley Allen, "Locating Chelerythrine, an Alkaloid, within a Cytosolic Environment by Maldi-Tof Mass Spectrometry" (2013). Browse all Theses and Dissertations. 1167. https://corescholar.libraries.wright.edu/etd_all/1167 This Thesis is brought to you for free and open access by the Theses and Dissertations at CORE Scholar. It has been accepted for inclusion in Browse all Theses and Dissertations by an authorized administrator of CORE Scholar. For more information, please contact [email protected]. LOCATING CHELERYTHRINE, AN ALKALOID, WITHIN A CYTOSOLIC ENVIRONMENT VIA MALDI-TOF MASS SPECTROMETRY A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science By BRADLEY ALLEN WILLIAMS BS., Youngstown State University, 2010 2013 Wright State University WRIGHT STATE UNIVERSITY GRADUATE SCHOOL December 11, 2013 I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY SUPERVISION BY Bradley Allen Williams ENTITLED Locating Chelerythrine, an Alkaloid within a Cytosolic Environment via MALDI-TOF Mass Spectrometry BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science ______________________________ Peter K. Lauf, MD., Thesis Director ___________________________ Norma C. Adragna, Ph.D., Interim Chair Pharmacology & Toxicology Committee on Final Examination __________________________________ Peter K. Lauf, MD. __________________________________ David R. Cool, Ph.D., Co-Director __________________________________ Norma C.
    [Show full text]